News & Insights

News & Insights

< Back to Bio
Christina M. Markus (Chris)

News 8 results

In the News · Source: Law.com

February 9, 2026
K&S’s Client Alert is referenced in a profile examining the Department of Health and Human Services’ Office of Inspector General’s guidance on direct-to-consumer drug sales

In the News · Source: PharmaCircle

November 25, 2025
Chris Markus provides insight on the FDA’s recent public meeting to discuss FDA PreCheck to accelerate the establishment of high priority new pharmaceutical manufacturing facilities in the U.S. and strengthen the domestic pharmaceutical supply chain

In the News · Source: PharmaVoice

July 18, 2025
K&S's Client Alert is referenced in a profile discussing the FDA publishing 200 complete response letters sent to pharma companies for drugs that were later approved

Recognition

September 19, 2024
King & Spalding Earns Multiple Rankings in LMG Life Sciences 2024 Guide

View all

Events 19 results

Webinar

May 20, 2026
Clinical Trials Under the Microscope: Navigating FDA’s New Rules and DOJ Enforcement

Conference

April 8, 2026
Annual California Life Sciences Summit

Speaking Engagement

April 2, 2026
Christina Markus and Geneviève Michaux to Speak at two European Cell and Gene Therapy Research Consortia

Webinar

January 8, 2026
Medicare and Medicaid Demos Seek To Impose Most Favored Nation Pricing: An Overview of GLOBE, GUARD, and GENEROUS

View all

Insights 21 results

Article · Source: Journal of Health Care Compliance

May 1, 2026
HHS-OIG Issues Guidance on Pharma DTC Prescription Drug Sales, but Key Legal Questions Remain

Client Alert

April 20, 2026
FDA Reminds Sponsors and Researchers to Disclose Clinical Trial Results to ClinicalTrials.gov

Client Alert

February 16, 2026
FDA Issues Refuse-to-File Letter for mRNA-based Vaccine BLA

Client Alert

February 2, 2026
HHS-OIG Issues Guidance on Pharma DTC Prescription Drug Sales, but Key Legal Questions Remain

View all